Conclusions
In this DO, open-label 1-year study, SDX/d-MPH was shown to be safe and well tolerated, with AEs that were comparable with those of other MPH products, with no new or unexpected safety findings. SDX/d-MPH also showed sustained efficacy during the 1-year treatment period.